MedTrace Logo

Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study

NCT07425587 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2026-07-02

No results posted yet for this study

Summary

The primary objective of this study is to establish an IL-6 concentration cutoff that predicts sepsis or septic shock (according to the Third International Consensus Definitions (Sepsis-3 criteria)) in patients who are admitted or are intended to be admitted to the hospital from the emergency department with suspected infection.

Conditions

  • Sepsis, Septic Shock

Sponsors & Collaborators

  • Bluejay Diagnostics, Inc.

    lead INDUSTRY

Principal Investigators

  • Shapiro · Beth Israel Deaconess Medical Center

  • Peltan · Intermountain Health

  • Marchick · University of Florida

  • Ware · Vanderbilt University Medical Center

  • Mahler · Wake Forest University Health Sciences

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-04
Primary Completion
2026-12-30
Completion
2026-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07425587 on ClinicalTrials.gov